1. Home
  2. CHMI vs IOBT Comparison

CHMI vs IOBT Comparison

Compare CHMI & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMI
  • IOBT
  • Stock Information
  • Founded
  • CHMI 2012
  • IOBT 2014
  • Country
  • CHMI United States
  • IOBT Denmark
  • Employees
  • CHMI N/A
  • IOBT N/A
  • Industry
  • CHMI Real Estate Investment Trusts
  • IOBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHMI Real Estate
  • IOBT Health Care
  • Exchange
  • CHMI Nasdaq
  • IOBT Nasdaq
  • Market Cap
  • CHMI 89.2M
  • IOBT 91.6M
  • IPO Year
  • CHMI 2013
  • IOBT 2021
  • Fundamental
  • Price
  • CHMI $2.79
  • IOBT $1.41
  • Analyst Decision
  • CHMI Hold
  • IOBT Strong Buy
  • Analyst Count
  • CHMI 2
  • IOBT 3
  • Target Price
  • CHMI N/A
  • IOBT $9.33
  • AVG Volume (30 Days)
  • CHMI 338.7K
  • IOBT 173.0K
  • Earning Date
  • CHMI 08-07-2025
  • IOBT 08-12-2025
  • Dividend Yield
  • CHMI 21.50%
  • IOBT N/A
  • EPS Growth
  • CHMI N/A
  • IOBT N/A
  • EPS
  • CHMI N/A
  • IOBT N/A
  • Revenue
  • CHMI $27,506,000.00
  • IOBT N/A
  • Revenue This Year
  • CHMI N/A
  • IOBT N/A
  • Revenue Next Year
  • CHMI $54.92
  • IOBT N/A
  • P/E Ratio
  • CHMI N/A
  • IOBT N/A
  • Revenue Growth
  • CHMI 19.59
  • IOBT N/A
  • 52 Week Low
  • CHMI $2.34
  • IOBT $0.66
  • 52 Week High
  • CHMI $3.95
  • IOBT $1.73
  • Technical
  • Relative Strength Index (RSI)
  • CHMI 45.14
  • IOBT 55.98
  • Support Level
  • CHMI $2.73
  • IOBT $1.37
  • Resistance Level
  • CHMI $2.82
  • IOBT $1.48
  • Average True Range (ATR)
  • CHMI 0.08
  • IOBT 0.09
  • MACD
  • CHMI -0.01
  • IOBT -0.01
  • Stochastic Oscillator
  • CHMI 40.00
  • IOBT 68.33

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: